{"id":"W1989963371","doi":"10.1002/ibd.21159","title":"Randomized, double-blind, placebo-controlled trial of the oral interleukin-12/23 inhibitor apilimod mesylate for treatment of active Crohn's disease","year":2009,"lang":"en","type":"article","venue":"Inflammatory Bowel Diseases","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":111,"is_retracted":false,"has_abstract":true,"ca_institutions":"Vale (Canada); St. Paul's Hospital; University of Alberta; University of Saskatchewan","funders":"","keywords":"Crohn's disease; Medicine; Internal medicine; Gastroenterology; Placebo; Double blind; Randomized controlled trial; Interleukin 23; Mesylate; Disease; Interleukin; Cytokine; Pathology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002255977,0.001934715,0.004482931,0.000507377,0.0007417809,0.001345976,0.001104994,0.002128488,0.008696577],"category_scores_gemma":[0.002396103,0.0009299057,0.001175514,0.0003922835,0.001508993,0.001130887,0.000438925,0.002700692,0.001410014],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006544998,"about_ca_system_score_gemma":0.001607438,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000678018,"about_ca_topic_score_gemma":0.00143754,"domain_scores_codex":[0.9989777,0.0005400956,0.00007100801,0.0001922783,0.00007954492,0.0001394201],"domain_scores_gemma":[0.9987112,0.0003654621,0.0002480377,0.0001058364,0.0001185184,0.0004510497],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9872148,0.00471355,0.0002443892,0.0003346505,0.0003117129,0.00002227146,0.00002446848,0.00007877812,0.001326971,0.00005406762,0.0004135519,0.005260698],"study_design_scores_gemma":[0.9759042,0.02299377,0.0004869339,0.00001112578,0.00008916606,0.00000963189,0.000005528287,0.0001298151,0.0001056514,0.00003613535,0.0002238648,0.000004282486],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9707353,0.00623614,0.001205147,0.001266278,0.002027399,0.01306735,0.001615046,0.0003049211,0.003542373],"genre_scores_gemma":[0.974115,0.002745066,0.002307679,0.002041752,0.001294061,0.01268046,0.001157391,0.00003332636,0.003625283],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008696577,"threshold_uncertainty_score":0.02909297,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01422193391407381,"score_gpt":0.2698773401754281,"score_spread":0.2556554062613543,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}